This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Arzneimittelwerk Dresden Gmbh, Other. Active years: 1989-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Moscow, SU (1989)
- Moscow, RU (2000)
Company Filing History:
Years Active: 1989-2000
Title: Vladimir G Granik: Innovator in Antiepileptic Compounds
Introduction
Vladimir G Granik is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiepileptic compounds. With a total of 3 patents, Granik's work has had a meaningful impact on medical science.
Latest Patents
Granik's latest patents include innovative compounds such as 4-amino-1-arylpyridin-2-ones, which are designed for use as antiepileptic agents. These compounds feature a complex formula that allows for various substitutions, enhancing their therapeutic potential. Another significant patent is for 1-thiocarbamylmethylpyrrolidine-2-thione, a novel compound that exhibits antihypoxic and nootropic activity. The process for preparing this compound involves a unique reaction with phosphorus pentasulfide, showcasing Granik's expertise in chemical synthesis.
Career Highlights
Throughout his career, Granik has worked with various organizations, contributing to advancements in pharmaceutical research. His experience has allowed him to develop a deep understanding of medicinal chemistry and the processes involved in creating effective therapeutic agents.
Collaborations
Granik has collaborated with notable colleagues such as Tatyana V Stezhko and Lidia F Roschina. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his research and inventions.
Conclusion
Vladimir G Granik stands out as an influential inventor in the field of pharmaceuticals, particularly in the development of antiepileptic compounds. His innovative work continues to contribute to advancements in medical science and offers hope for improved treatments for epilepsy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile